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provocation can be reduced by apocynin. However, the protein expression of NADPH
oxidase’s subunit, p22phox and gp91phox have no signiﬁcant difference among all
the groups. Regarding the MAPK pathway, the phosphorylation level of JNK 1 and
p38 are up-regulated and apocynin can reduce the protein expression levels of their
phosphorylation (P<0.01). The downstream ﬁbrosis-related protein MMP9 is over-
expressed by up-mentioned stimulation and can be reduced by apocynin (P<0.05).
Conclusions: High concentration of glucose and H2O2 promote the proliferation of
atrial ﬁbroblast and the combined stimulus has more remarkable effects. Similarly to
the mechanism of H2O2, glucose enhances the expression of ﬁbrosis-related protein
MMP 9 through up-regulating the function of NADPH oxidase and the expression and
phosphorylation level of JNK 1 and p38. Apocynin, a NADPH oxidase inhibitor, can
reduce the up-regulation of NADPH oxidase/MAPK/MMP 9 signal pathway and
suppress the abnormal proliferation of atrial ﬁbroblast.
GW25-e2527
Inhibition of the NF-kB pathway by the R65 ribozyme gene via adeno-associated
virus serotype 9 in human umbilical vein endothelial cells
Zhai Hui1,2, Yang Yi-ning1,2,3, Ma Yi-tong1,2
1Department of Cardiology, First Afﬁliated Hospital of Xinjiang Medical University,
Urumqi, China, 2Xinjiang Key Laboratory of Cardiovascular Disease Research,
Urumqi, China, 3The institution of clinical research, First Afﬁliated Hospital of
Xinjiang Medical University, Urumqi, China
Objectives: NF-kB signaling plays a central role in the regulation of inﬂammatory re-
sponses in atherosclerosis. To our knowledge, it is less intensively studied whether R65
ribozyme gene can decrease the expression of NF-kB pathway. Therefore, we used a
recombinant adeno-associated virus serotype 9 vector to deliver the R65 ribozyme gene
(rAVV9-R65) into oxidized LDL (ox-LDL) induced human umbilical vein endothelial
cells (HUVECs).We also assessedwhether rAAV9vector-mediatedR65 ribozyme gene
transfection can be expressed for a longterm and inhibit the activity of NF-kB.
Methods: rAVV9-R65 was transfected into HUVECs at different multiplicities of
infection, which was measured by ﬂow cytometry.The activity of NF-kB pathway was
analyzed by Western blot and Immunoﬂuorescencestaining.NF-kB inﬂammatory
factors and endothelial cell function markers were measured by ELISA. Cell apoptosis
was detected by Flow cytometry.
Results: The effects of the rAVV9-R65 upon ox-LDL induced injury of the HUVECs
were evaluated. First, rAVV9-R65 was transfected into HUVECs at different multi-
plicities of infection and it could be stably and efﬁciently expressed. Second, ox-LDL
led to concurrent increased NF-kB expression in a dose- and time-dependent manner,
and it increased inﬂammatory factors (TNF-a, IL-6) and cell apoptosis in HUVECs.
Third, over-expression of rAVV9-R65 gene could inhibit the NF-kB pathway and
protect HUVECs against ox-LDL induced cell apoptosis.
Conclusions: These results demonstrate thatAAV9-mediated R65 ribozyme gene
transfection may inhibit the expression of NF-kBand consequently down-regulate the
expression of downstream components of NF-kB and its transcription factors.
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Objectives: Adipose tissue receptors C5aR and C5L2 and their heterodimerization/
functionality and interaction with ligands C5a and acylation stimulating protein (ASP)
have been evaluated in cell and rodent studies. Their contribution to coronary artery
disease (CAD) factors in humans remains unclear. We hypothesized that C5a
receptors, classically required for host defense, are also associated with CAD.
Methods: Anthropometry and fasting blood parameters were measured in 492 CAD
patients and 577 control subjects.
Results: C5L2 gene Heterozygote carriers of the CT genotype were more frequent
among CAD patients than among controls (7.3% versus 1.7%). The odds ratio (OR) for
carriers of the CT genotype for CAD was 4.484 (95% conﬁdence interval (CI) :
2.197-9.174). C5aR gene Heterozygote carriers of the CT genotype were more frequent
among CAD patients than among controls (4.7%versus1.6%). The odds ratio (OR) for
carriers of the 698CT genotype for CAD was 4.484 (95% conﬁdence interval (CI) :
2.197-9.174), C5a gene Omental C5L2/C5a Rratio increased with BMI (P<0.01) with
correlations between C5L2/C5aR and waist circumference, HDL-C, and adiponectin.
Conclusions: Suggest relationship to The CT genotype of C5L2 and C5aR gene may
be a genetic maker of CAD and highlight adipose-immune interactions.
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gene polymorphisms (rs2298423 and rs6986132) and association with serum lipid in
Han and Uighur populations in Xinjiang.
Methods: The genotypes of the ADRB3 gene were detected in 362 Uighur and 653
Han healthy individuals by real-time PCR (TaqMan).
Results: (1) The frequencies of TT, GTand GG genotypes of the rs2298423 locus
were 76.5%,22.1% and 1.4% in the Uighurs, and 74.7%,23.3% and 2.0% in the
Hans.There was no signiﬁcant difference in distribution of genotypes between the two
populations (P¼0.695); (2) The frequencies of GG,AG and AA genotypes of the
rs6986132 locus were 81.5%,16.6% and 1.9% in Uighurs, and 59.6%,33.7% and 6.7%
in Hans.There was signiﬁcant difference in distribution of genotypes between the two
populations (P<0.001); (3) Total cholesterol and low density lipoprotein cholesterol
level were signiﬁcantly higher in GG or GT genotype than in TT genotype carrier of
rs2298423 in Uighur individuals, but not in Han populations. The serum lipid level
which include TC, LDL-C, TG, HDL-C were no signiﬁcant difference in distribution
of rs6986132genotypes between the two populations. After adjusting for gender,
age, height, weight, waist circumference, blood urea nitrogen, creatinine, glucose,
triglyceride, smoking, drinking, logistic regression analyses revealed that individuals
carrying GG or GT genotype of rs2298423 face an increased risk for total cholesterol
and low density lipoprotein cholesterol level than individuals carrying TT genotype in
Uighur populations (OR¼3.140,95%CI:1.270-7.764 in TC level, OR¼3.818,95%
CI:1.761-8.280 in LDL-C level); (4) The T-G haplotype was more frequent in the
Uighur but the T-A haplotype was more common in the Han population, respectively
(both P<0.001).
Conclusions: The mutational frequencies of the tagging SNPs in rs2298423 and
rs6986132 loci of the ADRB3 gene have obvious differences in Chinese Han and
Uighur populations of Xinjiang. G allele carriers of rs2298423 face an increased risk
for total cholesterol and low density lipoprotein cholesterol level in Uighur pop-
ulations in Xinjiang.
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Objectives: Serum amyloid A protein (SAA) is not only an inﬂammatory factor but
also an apolipoprotein that can replace apolipoprotein A1 (apoA1) as the major
apolipoprotein of HDL. However, the relationship between genetic polymorphisms of
SAA and coronary artery disease (CAD) remains unclear.
Methods: 4 Single Nucleotide Polymorphisms (rs12218, rs4638289, rs7131332, and
rs11603089) of SAA gene were genotyped by use of polymerase chain reaction -
restriction fragment length polymorphism (PCR - RFLP) method in two independent
case-control studies: one was in the Han population (1 416 CAD patients and 1 373
control subjects) and the other was in the Uygur population (588 CAD patients and
529 control subjects).
Results: We found rs12218 CC genotype were more frequent among CAD patients
than among controls not only in the Han population (8.3% versus 4.8%, P<0.001) but
also in the Uygur population (15.5% versus 11.3%, P<0.05). After adjustment of
confounding factors such as sex, age, smoking, drinking, hypertension, diabetes,
serum levels of triglyceride, total cholesterol, high density lipoprotein, the difference
remained signiﬁcant in the Han group (P<0.001, OR¼5.906, 95% CI: 2.877-12.124)
and in the Uygur group (P¼0.026, OR¼3.288, 95% CI: 1.015-6.671).
Conclusions: Genetic polymorphisms of SAA1 may be a genetic maker of CAD in
the Han and Uygur population in western China.
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Objectives: This study aimed to investigate whether acute or chronic administration
of the Resveratrol (3, 5, 4’-trihydroxystilbene) affect the cardioprotective effects of
ischemic postconditioning (Ipost) in diabetic and non-diabetic rat hearts.
Methods: Isolated rat hearts were subjected to 30 min of global ischemia, followed by
120 min of reperfusion. The hearts were subjected to the following treatments: non-
conditioning, Ipost (six cycles of 10-s reperfusion-ischemia after ischemia), acute
Resveratrol (10 mmol/l Resveratrol during reperfusion), acute Resveratrol with Ipost,
chronic Resveratrol (10 mg/kg/day Resveratrol for 2 weeks), and chronic Resveratrol
with Ipost. Infarct size, haemodynamics and expression of Akt and eNOS were
examined.
Results: Our results show that Ipost did not limit infarct size and recover contractile
dysfunction in the hearts of diabetic rats (infarct size: 58.1% and 59.2%, P>0.05).
Acute Resveratrol treatment with Ipost resulted in infarct size-limiting and contractile
dysfunction-recovering effects in both diabetic and non-diabetic hearts (infarct size:
38.8% and 59.2% in diabetic ones and 24.3% and 43.7% in non-diabetic ones, P<0.05,
respectively), and produced a further activation of Akt and eNOS signaling pathways toer 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
